Brammer leans on Pall for $50m cell & gene therapy plant expansions – BioPharma-Reporter.com
BioPharma-Reporter.com |
Brammer leans on Pall for $50m cell & gene therapy plant expansions
BioPharma-Reporter.com This year, Brammer Bio has invested in its biomanufacturing capabilities, with a $40m expansion at its late-stage and commercial-ready cell and gene therapy facility in Cambridge, Massachusetts and a $10m expansion at a Phase I/II plant in Alachua, … |
